Effects of sibutramine on magnetic resonance imaging outcomes under fasting conditions in obese women.

Trial Profile

Effects of sibutramine on magnetic resonance imaging outcomes under fasting conditions in obese women.

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Aug 2012

At a glance

  • Drugs Sibutramine (Primary)
  • Indications Obesity
  • Focus Pharmacodynamics
  • Most Recent Events

    • 18 Aug 2012 New trial record
    • 01 Jun 2012 Results published in the Psychopharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top